Searchable abstracts of presentations at key conferences in endocrinology

ea0016p288 | Endocrine tumours | ECE2008

Effects of the potent deacetylase inhibitor Panobinostat (LBH589) against poorly differentiated and anaplastic thyroid cancer cells

Catalano Maria Graziella , Pugliese Mariateresa , Bosco Ornella , Fortunati Nicoletta , Boccuzzi Giuseppe

Poorly differentiated and anaplastic thyroid carcinomas are aggressive human cancers that are resistant to conventional therapy. DAC inhibitors (DACi) are a promising class of drugs, acting as anti-proliferative agents by inducing apoptosis and cell cycle arrest.Panobinostat (LBH589) is a potent DACi belonging to a structurally novel cinnamic hydroxamic acid class of compounds, able to inhibit the activity of different isoforms of HDACs (HDAC 1, 3–6...